Baseline blood count levels increase odds of cytopenia among CML patients in Kenya: a case control study

BACKGROUND: Imatinib is the gold standard for the treatment of all phases of Philadelphia positive Chronic Myeloid Leukemia (CML). During treatment, patients may develop cytopenia. We aimed to study the baseline characteristics and factors associated with cytopenia at a Nairobi Hospital. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: McLigeyo, Angela, Rajab, Jamilla, Oyiro, Peter, Ezzi, Mohammed, Bett, Yatich, Ong’ondi, Matilda, Odhiambo, Andrew, Mwanzi, Sitna, Othieno-Abinya, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805406/
https://www.ncbi.nlm.nih.gov/pubmed/35105321
http://dx.doi.org/10.1186/s12885-021-09162-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805406/
https://www.ncbi.nlm.nih.gov/pubmed/35105321
http://dx.doi.org/10.1186/s12885-021-09162-z

Ejemplares similares